Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1998
12/02/1998CN1200736A Peptide derivatives
12/02/1998CN1200674A Establishment of TONIC ovarian estrogen secretion for extended therapeutic regimens
12/02/1998CN1200374A Vitronectin receptor antagonists, their prepn. and their use
12/02/1998CN1200276A Medicine for lowering blood-sugar and nourishing the heart and method for preparing same
12/02/1998CN1200274A Compound health-care food
12/02/1998CN1040985C Method for prepn. of benzo-aza-tropilidene compound
12/02/1998CA2230963A1 A human 7-tm receptor similar to murine frizzled-6 gene
12/01/1998US5844099 Cytokine antagonists
12/01/1998US5844098 Reconstituted platelet membrane vesicles
12/01/1998US5844095 CTLA4 Ig fusion proteins
12/01/1998US5844094 Target binding polypeptide
12/01/1998US5844093 Anti-EGFR single-chain Fvs and anti-EGFR antibodies
12/01/1998US5844092 Human TRK receptors and neurotrophic factor inhibitors
12/01/1998US5844090 Modified hemoglobin-like compounds
12/01/1998US5844089 Genetically fused globin-like polypeptides having hemoglobin-like activity
12/01/1998US5844088 Hemoglobin-like protein comprising genetically fused globin-like polypeptides
12/01/1998US5844085 Cloning and expression of simian transforming growth factor β1
12/01/1998US5844084 Chemokine expressed in inflamed adenoid
12/01/1998US5844082 Human acute phase response factor
12/01/1998US5844081 Cytostatin I
12/01/1998US5844080 CRF binding protein
12/01/1998US5844079 Vertebrate embryonic pattern-inducing proteins, and uses related thereto
12/01/1998US5844078 Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides
12/01/1998US5844077 Use of conantokins for producing analgesia or for neuroprotection
12/01/1998US5844075 Melanoma antigens and their use in diagnostic and therapeutic methods
12/01/1998US5844074 Cyclic CRF agonists
12/01/1998US5844073 Human NIK proteins
12/01/1998US5844072 Antibiotic cryptdin peptides and methods of their use
12/01/1998US5843994 Compositions and methods for treating and preventing pathologies including cancer
12/01/1998US5843961 Method and composition for treating erectile dysfunction
12/01/1998US5843960 Inhibitors of rotamase enzyme activity
12/01/1998US5843946 α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
12/01/1998US5843941 Ras farnesyl transferase inhibitors
12/01/1998US5843914 Neurturin and related growth factors
12/01/1998US5843905 Peptidic phosphinyloxymethyl ketones as interleukin-1β-converting enzyme inhibitors
12/01/1998US5843904 Inhibitors of interleukin-1βconverting enzyme
12/01/1998US5843903 Targeted cytotoxic anthracycline analogs
12/01/1998US5843902 Methods for treating prostate cancer with LHRH antagonists
12/01/1998US5843901 LHRH antagonist peptides
12/01/1998US5843900 Bradykinin antagonists
12/01/1998US5843899 Use of insulin-like growth factors I and II for inhibition of inflammatory response
12/01/1998US5843897 Platelet aggregation inhibitors
12/01/1998US5843895 Pharmaceutical administration of ecotin homologs
12/01/1998US5843894 Methods for reduced renal uptake of antibody fragments
12/01/1998US5843892 Stimulation of nerve growth and/or vitality
12/01/1998US5843891 Pharmaceutical acceptable compositions containing an alcohol and a hydrophobic drug
12/01/1998US5843890 Antibiotic GE 2270 factors B1, B2, C1, C2, D1, D2, E and T
12/01/1998US5843889 Glycopeptide antibiotic derivatives
12/01/1998US5843888 Low oxygen affinity mutant hemoglobin
12/01/1998US5843887 Compositions for delivery of polypeptides, and methods
12/01/1998US5843886 Method of treating or preventing Type 1 diabetes by oral administration of insulin
12/01/1998US5843885 ICAM-1/LFA-1 short-chain peptides and method of using same
12/01/1998US5843884 C9 complement inhibitor
12/01/1998US5843883 Methods of wound healing and treating hyperproliferative diseases of epidermis comprising administering trunicated keratinocyte growh factor (KGF) having increased biological activity
12/01/1998US5843882 Antiviral proteins and peptides
12/01/1998US5843778 Use of chimeric vaccinia virus complement control proteins to inhibit complement
12/01/1998US5843776 Method of expressing genes in mammalian cells
12/01/1998US5843775 Human dorsal tissue affecting factor (noggin) and nucleic acids encoding same
12/01/1998US5843774 Polypeptides for promoting cell attachment
12/01/1998US5843773 Apoptosis regulating gene
12/01/1998US5843770 Antisense constructs directed against viral post-transcriptional regulatory sequences
12/01/1998US5843761 CDNA coding for carcinoembryonic antigen
12/01/1998US5843755 Group of antitumor compounds and method for producing the same
12/01/1998US5843748 Trehalose phosphorylase its preparation and uses
12/01/1998US5843743 Gels for encapsulation of biological materials
12/01/1998US5843737 Cancer associated gene protein expressed therefrom and uses thereof
12/01/1998US5843736 Prevention of viral infection by the induction of apoptosis and/or the use of an antiviral gene, hem1
12/01/1998US5843730 Method for hypermutagenesis of nucleotides
12/01/1998US5843728 Redirection of cellular immunity by receptor chimeras
12/01/1998US5843727 Polynucleotides encoding a human tumor-associated membrane protein
12/01/1998US5843726 Expression of a cleavable fusion protein comprising a soluble human erythropoietin receptor protein fragment
12/01/1998US5843725 Methods of producing secreted receptor analogs and biologically active dimerized polypeptide fusions
12/01/1998US5843724 Chimeric nucleic acids and proteins for inhibiting HIV-1 expression
12/01/1998US5843723 Alphavirus vector constructs
12/01/1998US5843721 Nucleic acids encoding human NIK protein
12/01/1998US5843719 Cellubrevin homolog
12/01/1998US5843717 Rab protein
12/01/1998US5843716 Polynucleotide encoding a proline-rich membrane protein
12/01/1998US5843715 Human proteasome subunit proteins
12/01/1998US5843714 DNA encoding a novel human proteolipid
12/01/1998US5843711 Diphtheria toxin receptor-binding region
12/01/1998US5843707 Nucleic acid encoding a novel P-selectin ligand protein
12/01/1998US5843705 Transgenically produced antithrombin III
12/01/1998US5843695 Method for decomposing amyloid protein precursor and amyloid β-protein
12/01/1998US5843693 Assay method for screening for inhibitors of proTNF conversion
12/01/1998US5843690 Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers
12/01/1998US5843688 Isolated tyrosinase derived peptides and uses thereof
12/01/1998US5843687 Isolated, tyrosinase derived peptides and uses thereof
12/01/1998US5843686 Methods of diagnosing metastatic cancer with MTS-1 protein
12/01/1998US5843685 Production of chimeric mouse-human antibodies with specificity to human tumor antigens
12/01/1998US5843678 Osteoprotegerin binding proteins
12/01/1998US5843676 Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications
12/01/1998US5843675 TNF receptor death domain ligand proteins and inhibitors of ligand binding
12/01/1998US5843672 Allergenic proteins and peptides from dog dander and uses therefor
12/01/1998US5843668 Human SQM1 protein homolog
12/01/1998US5843648 P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
12/01/1998US5843646 DNA molecules encoding murine son of sevenless (mSOS) gene and mSOS polypeptides
12/01/1998US5843642 Methods for detection of acute promyelocytic leukemia (APL)
12/01/1998US5843641 Methods for the daignosis, of familial amyotrophic lateral sclerosis
12/01/1998US5843639 Hepatitis C virus epitopes
1 ... 2566 2567 2568 2569 2570 2571 2572 2573 2574 2575 2576 2577 2578 2579 2580 2581 2582 2583 2584 2585 2586 ... 3163